In last trading session, Metagenomi Inc (NASDAQ:MGX) saw 1.9 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $3.86 trading at $0.75 or 24.12% at ring of the bell on the day assigns it a market valuation of $144.46M. That closing price of MGX’s stock is at a discount of -230.05% from its 52-week high price of $12.74 and is indicating a premium of 58.29% from its 52-week low price of $1.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.62 million shares which gives us an average trading volume of 1.68 million if we extend that period to 3-months.

For Metagenomi Inc (MGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.58 in the current quarter.

Metagenomi Inc (NASDAQ:MGX) trade information

Metagenomi Inc’s shares saw a change of -62.56% in year-to-date performance and have moved 0.00% in past 5-day. Metagenomi Inc (NASDAQ:MGX) showed a performance of 128.40% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 0.6 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 7 to the stock, which implies a rise of 44.86% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 7. It follows that stock’s current price would drop -81.35% in reaching the projected high whereas dropping to the targeted low would mean a loss of -81.35% for stock’s current value.

Metagenomi Inc (MGX) estimates and forecasts

Statistics highlight that Metagenomi Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 7.82% of value to its shares in past 6 months, showing an annual growth rate of 87.73% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 15.35% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 9.46M for the same. And 2 analysts are in estimates of company making revenue of 6.25M in the next quarter. Company posted 12.4M and 11.16M of sales in current and next quarters respectively a year earlier.